Tenaya Therapeutics, Inc. Quarterly Debt-to-equity in % from Q1 2022 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Tenaya Therapeutics, Inc. quarterly Debt-to-equity history and growth rate from Q1 2022 to Q3 2024.
  • Tenaya Therapeutics, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 21.1 %, a 37.7% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 21.1 +5.79 +37.7% Sep 30, 2024
Q2 2024 19.4 +4.42 +29.6% Jun 30, 2024
Q1 2024 18 +3.44 +23.7% Mar 31, 2024
Q4 2023 17 +2.71 +19% Dec 31, 2023
Q3 2023 15.3 +1.62 +11.8% Sep 30, 2023
Q2 2023 15 +2.79 +23% Jun 30, 2023
Q1 2023 14.5 -2.21 -13.2% Mar 31, 2023
Q4 2022 14.3 Dec 31, 2022
Q3 2022 13.7 Sep 30, 2022
Q2 2022 12.2 Jun 30, 2022
Q1 2022 16.7 Mar 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.